市場調查報告書
商品編碼
1044183

蛋白質工程的全球市場:各類型,各用途,各手法,各終端用戶,各地區 -至2027年的預測

Protein Engineering Market: Information by Type, by Application, by Method, by End User, and Region -Forecast till 2027

出版日期: | 出版商: Market Research Future | 英文 132 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球蛋白質工程市場,至2027年超過30億2,329萬美元,在預測期間內預計以7.62%的年複合成長率大幅度成長。蛋白質醫藥品,預期在臨床領域的效果。蛋白質工程設備的利用,在臨床領域帶來相當多的優點。

本報告提供全球蛋白質工程市場相關調查分析,市場動態,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 調查手法

第4章 市場動態

  • 概要
  • 促進因素
  • 阻礙因素
  • 機會

第5章 市場要素分析

  • 價值鏈分析
  • 波特的五力分析
  • COVID-19對蛋白質工程市場的影響

第6章 全球蛋白質工程市場:各類型

  • 概要
  • 設備
  • 試劑
  • 服務、軟體

第7章 全球蛋白質工程市場:各用途

  • 概要
  • 食品、清潔劑
  • 環境
  • 醫療
  • 生物聚合物生產
  • 奈米生物科技

第8章 全球蛋白質工程市場:各手法

  • 概要
  • 合理的蛋白質設計
  • 定向演進法

第9章 全球蛋白質工程市場:各終端用戶

  • 概要
  • 製藥、生物科技企業
  • 受託工程組織
  • 學術研究機關

第10章 全球蛋白質工程市場:各地區

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他的亞太地區
  • 中東、非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 阿曼
    • 科威特
    • 卡達
    • 其他的中東、非洲

第11章 競爭情形

  • 概要
  • 競爭基準
  • 蛋白質工程市場上主要成長策略
  • 蛋白質工程市場上主要企業 (開發數量)
  • 主要的開發分析
  • 主要的開發與成長策略
  • 主要企業的銷售分析
  • 主要企業的R&D分析

第12章 企業簡介

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • GENSCRIPT
  • AGILENT TECHNOLOGIES, INC.
  • PERKINELMER INC.
  • BRUKER
  • WATERS CORPORATION
  • MERCK KGAA
  • PROMEGA CORPORATION
  • DANAHER CORPORATION (AB-SCIEX)

第13章 附錄

目錄
Product Code: MRFR/HC/0220-CR

Protein Engineering Market Forecast till 2027

Protein Engineering Market overview

The protein engineering market is anticipated to register a significant CAGR of 7.62% during the review period to surpass USD 3,023.29 million by 2027. Nowadays, the protein engineering market is acquiring fame because of less utilization of non-protein drugs. The consequences of protein drugs are positive in the clinical area. Because of this, the interest in protein engineering is expanding in numerous areas. Protein engineering has an enormous degree as it can decrease the shortcoming of clinical medications. Likewise, the proficiency and viability of the medication are high. Generally, the pervasiveness of protein engineering brings about more cardiovascular fixes. The utilization of the protein engineering device is prompting considerably more advantages in the clinical area.

The therapy of disease, immune system, and relocate dismissals are conceivable through protein engineering. Additionally, the all-around designed methods of protein in drugs are giving remarkable outcomes and conveyance. The expanding innovative work interest in the wellbeing area is the vital justification behind the popularity. Likewise, really advertising and commercialization of the medications is one more justification for more interest. There is a mixture of protein engineering techniques and applications in the impending years. Particularly the biotechnical drug organization holds the most extreme protein piece of the pie. The ascent of the reception of silicon model protein in this area is promoting a positive effect on the protein engineering market. It will prompt further improvement of the general market.

Segment overview

The global protein engineering market has been classified based on product, protein type, technology, and end-user.

In terms of product segment, the global market has been divided into Instruments, Consumables, and Services, and software. Based on Protein type the market has been classified into Coagulation factors, Monoclonal antibodies, Growth hormones, Vaccines, Vaccines, and Interferon.

Based on Technology type the market has been categorized into Irrational protein design and Rational protein design.

The End-user segment segregates the global protein engineering market into Academic research institutes, biopharmaceutical companies, and Contract research organizations.

Regional analysis

The region-specific analysis of the global protein engineering market is studied across Asia Pacific, North America, and Europe.

North America is set to overwhelm the market with the biggest offer. Further, the developing venture is the main consideration for a market extension. The market advancement rate will be higher for the North American region. The rising technique of extent protein engineering is driving more interest.

The Asia Pacific market is rapidly occupying in the projected timeframe. The high advancement is a direct result of more care about protein engineering. The progression in genomics is the earnest driver for the market. Further, the advancement of proteomics is higher around here. The regulatory drives for the medicine-based market are higher. The allotments support protein engineering turning out to be more. Additionally, Europe is standing up to direct revenue for the market around here. Europe will see greater improvement during the review period.

Prominent Players

The key player of the protein engineering market is ProteoGenix, Bio-Rad Laboratories, PhyNexus, Inc, Thermo Fisher Scientific, Broker Corporation, Zymeworks, Inc, Waters Corporation, Aspira Chemical, Danaher Corporation, InvivoGen, New England Biolabs, Enantis S.R.O, New England Biolabs, Promega Corporation, and New England Biolabs.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 MARKET STRUCTURE
  • 2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
    • 4.2.2 INCREASING INVESTMENTS IN SYNTHETIC BIOLOGY
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF TRAINED PROFESSIONALS
  • 4.4 OPPORTUNITIES
    • 4.4.1 EMERGING MARKETS OF PROTEIN ENGINEERING

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE PROTEIN ENGINEERING MARKET
    • 5.3.1 IMPACT ON DEMAND
    • 5.3.2 IMPACT ON RESEARCH
    • 5.3.3 IMPACT ON SUPPLY CHAIN

6 GLOBAL PROTEIN ENGINEERING MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 INSTRUMENT
  • 6.3 REAGENT
  • 6.4 SERVICES & SOFTWARE

7 GLOBAL PROTEIN ENGINEERING MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 FOOD & DETERGENT INDUSTRIES
  • 7.3 ENVIRONMENTAL
  • 7.4 MEDICAL
  • 7.5 BIOPOLYMER PRODUCTION
  • 7.6 NANOBIOTECHNOLOGY

8 GLOBAL PROTEIN ENGINEERING MARKET, BY METHOD

  • 8.1 OVERVIEW
  • 8.2 RATIONAL PROTEIN DESIGN
  • 8.3 DIRECTED EVOLUTION

9 GLOBAL PROTEIN ENGINEERING MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES
  • 9.3 CONTRACT ENGINEERING ORGANIZATIONS
  • 9.4 ACADEMIC RESEARCH INSTITUTES

10 GLOBAL PROTEIN ENGINEERING MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 AMERICAS
    • 10.2.1 NORTH AMERICA
      • 10.2.1.1 US
      • 10.2.1.2 CANADA
    • 10.2.2 SOUTH AMERICA
  • 10.3 EUROPE
    • 10.3.1 WESTERN EUROPE
      • 10.3.1.1 GERMANY
      • 10.3.1.2 FRANCE
      • 10.3.1.3 UK
      • 10.3.1.4 ITALY
      • 10.3.1.5 SPAIN
      • 10.3.1.6 REST OF WESTERN EUROPE
    • 10.3.2 EASTERN EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 JAPAN
    • 10.4.2 CHINA
    • 10.4.3 INDIA
    • 10.4.4 AUSTRALIA
    • 10.4.5 SOUTH KOREA
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 UAE
    • 10.5.2 SAUDI ARABIA
    • 10.5.3 OMAN
    • 10.5.4 KUWAIT
    • 10.5.5 QATAR
    • 10.5.6 REST OF THE MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 COMPETITIVE BENCHMARKING
  • 11.3 MAJOR GROWTH STRATEGY IN THE PROTEIN ENGINEERING MARKET
  • 11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PROTEIN ENGINEERING MARKET
  • 11.5 KEY DEVELOPMENT ANALYSIS
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES/PIPELINE DRUGS
    • 11.6.2 PARTNERSHIP/COLLABORATION
    • 11.6.3 EXPANSIONS/AGREEMENT
    • 11.6.4 MARKETING STRATEGY
    • 11.6.5 MERGERS & ACQUISITIONS
  • 11.7 MAJOR PLAYERS SALES ANALYSIS
    • 11.7.1 SALES & OPERATING INCOME
  • 11.8 MAJOR PLAYERS R&D ANALYSIS

12 COMPANY PROFILES

  • 12.1 THERMO FISHER SCIENTIFIC INC.
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS/SERVICES OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 BIO-RAD LABORATORIES, INC.
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS/SERVICES OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 GENSCRIPT
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS/SERVICES OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 SWOT ANALYSIS
    • 12.3.6 KEY STRATEGIES
  • 12.4 AGILENT TECHNOLOGIES, INC.
    • 12.4.1 COMPANY OVERVIEWS
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS/SERVICES OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 SWOT ANALYSIS
    • 12.4.6 KEY STRATEGIES
  • 12.5 PERKINELMER INC.
    • 12.5.1 COMPANY OVERVIEWS
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS/SERVICES OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 SWOT ANALYSIS
    • 12.5.6 KEY STRATEGIES
  • 12.6 BRUKER
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS/SERVICES OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 SWOT ANALYSIS
    • 12.6.6 KEY STRATEGIES
  • 12.7 WATERS CORPORATION
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS/SERVICES OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 SWOT ANALYSIS
    • 12.7.6 KEY STRATEGIES
  • 12.8 MERCK KGAA
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS/SERVICES OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 SWOT ANALYSIS
    • 12.8.6 KEY STRATEGIES
  • 12.9 PROMEGA CORPORATION
    • 12.9.1 COMPANY OVERVIEWS
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS/SERVICES OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 SWOT ANALYSIS
    • 12.9.6 KEY STRATEGIES
  • 12.10 DANAHER CORPORATION (AB-SCIEX)
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS/SERVICES OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 SWOT ANALYSIS
    • 12.10.6 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
  • 13.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL: PROTEIN ENGINEERING MARKET, FOR INSTRUMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL: PROTEIN ENGINEERING MARKET, FOR REAGENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL: PROTEIN ENGINEERING MARKET, FOR SERVICES & SOFTWARE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL: PROTEIN ENGINEERING MARKET FOR FOOD & DETERGENT INDUSTRIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL: PROTEIN ENGINEERING MARKET, FOR ENVIRONMENTAL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL: PROTEIN ENGINEERING MARKET, FOR MEDICAL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL: PROTEIN ENGINEERING MARKET, FOR BIOPOLYMER PRODUCTION, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL: PROTEIN ENGINEERING MARKET, FOR NANOBIOTECHNOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL: PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL: PROTEIN ENGINEERING MARKET, FOR DIRECTED EVOLUTION, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL: PROTEIN ENGINEERING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 GLOBAL: PROTEIN ENGINEERING MARKET, FOR CONTRACT ENGINEERING ORGANIZATIONS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 GLOBAL: PROTEIN ENGINEERING MARKET, FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20 GLOBAL: PROTEIN ENGINEERING MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 AMERICAS: PROTEIN ENGINEERING MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22 AMERICAS: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 23 AMERICAS: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 24 AMERICAS: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 25 AMERICAS: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 26 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 31 US: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 32 US: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 33 US: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 34 US: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 35 CANADA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 36 CANADA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 37 CANADA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 38 CANADA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 39 SOUTH AMERICA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 40 SOUTH AMERICA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 41 SOUTH AMERICA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 42 SOUTH AMERICA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 43 EUROPE: PROTEIN ENGINEERING MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 44 EUROPE: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 EUROPE: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 46 EUROPE: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 47 EUROPE: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 48 WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 49 WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 51 WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 52 WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 53 GERMANY: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 54 GERMANY: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 55 GERMANY: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 56 GERMANY: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 57 FRANCE: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 FRANCE: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 59 FRANCE: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 60 FRANCE: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 61 UK: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 62 UK: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 63 UK: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 64 UK: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 65 ITALY: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 66 ITALY: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 67 ITALY: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 68 ITALY: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 69 SPAIN: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 SPAIN: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 71 SPAIN: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 72 SPAIN: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 73 REST OF WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 74 REST OF WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 75 REST OF WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 76 REST OF WESTERN EUROPE: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 77 EASTERN EUROPE: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 78 EASTERN EUROPE: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 79 EASTERN EUROPE: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 80 EASTERN EUROPE: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 86 JAPAN: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 87 JAPAN: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 88 JAPAN: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 89 JAPAN: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 90 CHINA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 91 CHINA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 92 CHINA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 93 CHINA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 94 INDIA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 95 INDIA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 96 INDIA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 97 INDIA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 98 AUSTRALIA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 99 AUSTRALIA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 100 AUSTRALIA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 101 AUSTRALIA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 102 SOUTH KOREA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 103 SOUTH KOREA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 104 SOUTH KOREA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 105 SOUTH KOREA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 106 REST OF ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 107 REST OF ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 108 REST OF ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 109 REST OF ASIA-PACIFIC: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 111 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 115 UAE: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 116 UAE: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 117 UAE: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 118 UAE: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 119 SAUDI ARABIA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 120 SAUDI ARABIA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 121 SAUDI ARABIA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 122 SAUDI ARABIA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 123 OMAN: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 124 OMAN: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 125 OMAN: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 126 OMAN: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 127 KUWAIT: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 128 KUWAIT: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 129 KUWAIT: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 130 KUWAIT: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 131 QATAR: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 132 QATAR: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 133 QATAR: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 134 QATAR: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 135 REST OF THE MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 136 REST OF THE MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 137 REST OF THE MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY METHOD, 2018-2027 (USD MILLION)
  • TABLE 138 REST OF THE MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 139 MAJOR MANUFACTURERS IN THE PROTEIN ENGINEERING MARKET
  • TABLE 140 BENCHMARKING OF MAJOR COMPETITORS
  • TABLE 141 MOST ACTIVE PLAYER IN THE PROTEIN ENGINEERING MARKET
  • TABLE 142 PRODUCT APPROVALS AND PRODUCT LAUNCHES/PIPELINE DRUGS
  • TABLE 143 PARTNERSHIP/COLLABORATION
  • TABLE 144 EXPANSION/ INVESTMENT
  • TABLE 145 MARKETING STRATEGY
  • TABLE 146 MERGERS & ACQUISITIONS
  • TABLE 147 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 148 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS
  • TABLE 149 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 150 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 151 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS
  • TABLE 152 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 153 PERKINELMER INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 154 PERKINELMER INC.: KEY DEVELOPMENTS
  • TABLE 155 BRUKER: PRODUCTS/SERVICES OFFERED
  • TABLE 156 BRUKER: KEY DEVELOPMENTS
  • TABLE 157 WATERS CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 158 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 159 MERCK KGAA: KEY DEVELOPMENTS
  • TABLE 160 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 161 PROMEGA CORPORATION: KEY DEVELOPMENTS
  • TABLE 162 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 163 DANAHER CORPORATION: KEY DEVELOPMENTS  

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PROTEIN ENGINEERING MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: PROTEIN ENGINEERING MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL PROTEIN ENGINEERING MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: PROTEIN ENGINEERING MARKET
  • FIGURE 9 GLOBAL PROTEIN ENGINEERING MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
  • FIGURE 11 GLOBAL: PROTEIN ENGINEERING MARKET, BY METHOD, 2020 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL: PROTEIN ENGINEERING MARKET, BY END USER, 2020 & 2027 (USD MILLION)
  • FIGURE 13 GLOBAL: PROTEIN ENGINEERING MARKET, BY REGION, 2020 & 2027 (USD MILLION)
  • FIGURE 14 GLOBAL: PROTEIN ENGINEERING MARKET SHARE (%), BY REGION, 2020
  • FIGURE 15 AMERICAS: PROTEIN ENGINEERING MARKET SHARE, BY REGION, 2020 (%)
  • FIGURE 16 NORTH AMERICA: PROTEIN ENGINEERING MARKET SHARE, BY COUNTRY, 2020 (%)
  • FIGURE 17 EUROPE: PROTEIN ENGINEERING MARKET SHARE (%), BY REGION, 2020
  • FIGURE 18 WESTERN EUROPE: PROTEIN ENGINEERING MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 19 ASIA-PACIFIC: PROTEIN ENGINEERING MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 20 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET SHARE (%), BY REGION, 2020
  • FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE PROTEIN ENGINEERING MARKET
  • FIGURE 22 PROTEIN ENGINEERING MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 23 MAJOR PLAYERS SALES & OPERATING INCOME, 2020
  • FIGURE 24 MAJOR PLAYERS R&D EXPENDITURE, 2020
  • FIGURE 25 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
  • FIGURE 27 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
  • FIGURE 29 GENSCRIPT: FINANCIAL OVERVIEW
  • FIGURE 30 GENSCRIPT: SWOT ANALYSIS
  • FIGURE 31 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 32 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
  • FIGURE 33 PERKINELMER INC.:FINANCIAL OVERVIEW
  • FIGURE 34 PERKINELMER INC.: SWOT ANALYSIS
  • FIGURE 35 BRUKER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 BRUKER: SWOT ANALYSIS
  • FIGURE 37 WATERS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 WATERS CORPORATION: SWOT ANALYSIS
  • FIGURE 39 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 MERCK KGAA: SWOT ANALYSIS
  • FIGURE 41 PROMEGA CORPORATION: SWOT ANALYSIS
  • FIGURE 42 DANAHER CORPORATION (AB-SCIEX):FINANCIAL OVERVIEW
  • FIGURE 43 DANAHER CORPORATION: SWOT ANALYSIS